| |
| |
|
| Insider
Information: |
Wasman Jane |
| Relationship: |
Director |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
262,961 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$195,763 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,961 |
|
|
| Total
Value |
$195,763 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
President, Intl and GC |
2019-12-02 |
117,420 |
|
0 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2024-05-25 |
100,000 |
2021-05-19 |
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2024-01-22 |
10,400 |
2022-01-31 |
0 |
Premium* |
|
|
Athersys Inc (New) |
ATHX |
Director |
2023-01-09 |
35,141 |
2022-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2017-02-09 |
4 |
AS |
$22.30 |
$1,216,218 |
D/D |
(54,536) |
101,674 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2017-02-09 |
4 |
OE |
$22.13 |
$1,206,882 |
D/D |
54,536 |
156,210 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-01-19 |
4 |
AS |
$27.58 |
$952,319 |
D/D |
(34,520) |
102,110 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-01-19 |
4 |
OE |
$19.81 |
$683,841 |
D/D |
34,520 |
136,630 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, St. Dev. and Gen. Coun |
• – – |
2012-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
104,970 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
75,000 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2024-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
100,000 |
0 |
- |
|
| ATHX |
Athersys Inc (New) |
Director |
– • – |
2023-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
22,321 |
35,141 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
• – – |
2006-11-06 |
4 |
AS |
$15.90 |
$353,121 |
D/D |
(22,000) |
55,615 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
• – – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
53,664 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
• – – |
2011-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
64,914 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, St. Dev. and Gen. Coun |
• – – |
2012-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,400 |
74,970 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2015-11-04 |
4 |
OE |
$5.85 |
$99,596 |
D/D |
16,822 |
114,919 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
• – – |
2008-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
28,589 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
• – – |
2009-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
38,664 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2014-08-27 |
4 |
AS |
$33.00 |
$492,459 |
D/D |
(14,923) |
105,284 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2014-08-27 |
4 |
OE |
$8.14 |
$121,473 |
D/D |
14,923 |
120,207 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2014-09-24 |
4 |
AS |
$36.00 |
$537,228 |
D/D |
(14,923) |
105,284 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2014-09-24 |
4 |
OE |
$8.14 |
$121,473 |
D/D |
14,923 |
120,207 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2014-11-03 |
4 |
AS |
$34.84 |
$519,949 |
D/D |
(14,923) |
101,534 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2014-11-03 |
4 |
OE |
$8.14 |
$121,473 |
D/D |
14,923 |
116,457 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2015-12-22 |
4 |
AS |
$42.07 |
$585,432 |
D/D |
(13,797) |
100,124 |
0 |
- |
|
| ATHX |
Athersys Inc (New) |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
12,820 |
12,820 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
